Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
Boulenger de Hauteclocque A, Ferrer L, Ambrosetti D, Ricard S, Bigot P, Bensalah K, Henon F, Doumerc N, Méjean A, Verkarre V, Dariane C, Larré S, Champy C, de La Taille A, Bruyère F, Rouprêt M, Paparel P, Droupy S, Fontenil A, Patard JJ, Durand X, Waeckel T, Lang H, Lebâcle C, Guy L, Pignot G, Durand M, Long JA, Charles T, Xylinas E, Boissier R, Yacoub M, Colin T, Bernhard JC. Boulenger de Hauteclocque A, et al. Among authors: long ja. BJU Int. 2023 Aug;132(2):160-169. doi: 10.1111/bju.15959. Epub 2023 Feb 1. BJU Int. 2023. PMID: 36648124
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, Patard JJ; Comité de Transplantation de l'Association Française d'Urologie; Comité de Cancérologie de l'Association Française d'Urologie. Neuzillet Y, et al. Among authors: long ja. Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2. Eur Urol. 2011. PMID: 21377780
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M; French Collaborative National Database on UUT-UC. Ouzzane A, et al. Eur Urol. 2011 Dec;60(6):1258-65. doi: 10.1016/j.eururo.2011.05.049. Epub 2011 Jun 7. Eur Urol. 2011. PMID: 21665356
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA, Soulie M, Phé V, Bensadoun H, Guy L, Ruffion A, Valeri A, Cormier L, Droupy S, de La Taille A, Saint F, Faïs PO, Houlgatte A, Cussenot O, Rouprêt M; French Collaborative National Database on UUT-UC. Audenet F, et al. Among authors: long ja. BJU Int. 2012 Dec;110(11 Pt B):E583-9. doi: 10.1111/j.1464-410X.2012.11298.x. Epub 2012 Jun 15. BJU Int. 2012. PMID: 22703159
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.
Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Polguer T, Ruffion A, Valeri A, Rozet F, Long JA, Zerbib M, Rouprêt M. Xylinas E, et al. Among authors: long ja. World J Urol. 2013 Feb;31(1):61-8. doi: 10.1007/s00345-012-0957-3. Epub 2012 Sep 30. World J Urol. 2013. PMID: 23053211
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.
Nison L, Rouprêt M, Bozzini G, Ouzzane A, Audenet F, Pignot G, Ruffion A, Cornu JN, Hurel S, Valeri A, Roumiguie M, Polguer T, Hoarau N, Mérigot de Treigny O, Xylinas E, Matte A, Droupy S, Fais PO, Descazeaud A, Colin P; MD for the French Collaborative National Database on UUT-UC. Nison L, et al. World J Urol. 2013 Feb;31(1):69-76. doi: 10.1007/s00345-012-0959-1. Epub 2012 Oct 16. World J Urol. 2013. PMID: 23070533
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M; French Collaborative National Database on UUT-UC. Pignot G, et al. Among authors: long ja. Urol Oncol. 2014 Jan;32(1):23.e1-8. doi: 10.1016/j.urolonc.2012.08.010. Epub 2013 Feb 9. Urol Oncol. 2014. PMID: 23403206
Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study.
Verhoest G, Patard JJ, Oger E, Rioux-Leclercq N, Peyronnet B, Bessède T, Laguna P, Barwari K, Rigaud J, Roupret M, Coffin G, Bernhard JC, Long JA, Zisman A, Berger J, Paparel P, Maurin C, Lechevallier E, Bertini R, Ouzaid I, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez AR, Bensalah K. Verhoest G, et al. Among authors: long ja. Urol Oncol. 2014 Jan;32(1):28.e21-6. doi: 10.1016/j.urolonc.2012.10.003. Epub 2013 Feb 19. Urol Oncol. 2014. PMID: 23428536
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
Bigot P, Fardoun T, Bernhard JC, Xylinas E, Berger J, Rouprêt M, Beauval JB, Lagabrielle S, Lebdai S, Ammi M, Baumert H, Escudier B, Grenier N, Hétet JF, Long JA, Paparel P, Rioux-Leclercq N, Soulié M, Azzouzi AR, Bensalah K, Patard JJ. Bigot P, et al. Among authors: long ja. World J Urol. 2014 Feb;32(1):109-14. doi: 10.1007/s00345-013-1088-1. Epub 2013 Apr 27. World J Urol. 2014. PMID: 23624719
506 results